Medication info
Pidobix Tablets (Clopidogrel Sulfate)

Pidobix Tablets (Clopidogrel Sulfate)

Prescription medicationTabletOral
Ingredient · strength
Clopidogrel Bisulfate›97.875mg / 1 tablet
Manufacturer / importer
Hanlim Pharmaceutical Co., Ltd.
Appearance
Pink round film-coated tablet
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 200502869 · Notified 2005.06.28 · Insurance code 645302760

Summary

Main use
Improvement of symptoms of acute coronary syndrome and atherosclerosis; prevention of thromboembolism in atrial fibrillation
Who takes it
Adults
Adult dose
○ Adults 1. For patients with ischemic stroke, myocardial infarction, or peripheral arterial disease, administer clopidogrel 75 mg orally once daily. 2. For patients with acute coronary syndrome (unstable angina or non-Q-wave myocardial infarction), start on the first day of treatment with a loading dose of 300 mg of this drug once daily, followed by a maintenance dose of 75 mg orally once daily. Aspirin 75 ~ 325 mg should be coadministered with this drug once daily. 3. For patients with atrial fibrillation, administer 75 mg of this drug orally once daily. Aspirin 75 ~ 100 mg should be coadministered with this drug once daily. ○ Patients with renal impairment : Treatment experience in patients with renal impairment is limited. ○ Patients with hepatic impairment : Treatment experience in patients with moderate hepatic disease and bleeding diathesis is limited. This drug may be administered with or without food.

Ingredients

Manufacturer
Hanlim Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of symptoms of acute coronary syndrome and atherosclerosis; prevention of thromboembolism in atrial fibrillation

  • Ischemic stroke
  • myocardial infarction
  • peripheral arterial disease
  • acute coronary syndrome
  • unstable angina
  • non-Q wave myocardial infarction
  • cardiovascular abnormalities
  • stroke
  • refractory ischemia
  • vascular risk factors
  • bleeding risk
  • atrial fibrillation.
View approved original text

This medication is used to improve atherosclerotic symptoms in adult patients suffering from ischemic stroke, myocardial infarction, and peripheral arterial disease. It also reduces the risks of cardiovascular events such as death due to cardiovascular abnormalities, myocardial infarction, and stroke in patients with acute coronary syndrome. In patients with atrial fibrillation who have one or more vascular risk factors and for whom vitamin K antagonists are not suitable, it helps reduce the risk of stroke and thromboembolism. This medication is effective for the prevention of cardiovascular disease and the improvement of symptoms.

How to take

Adult dose

○ Adults 1. For patients with ischemic stroke, myocardial infarction, or peripheral arterial disease, administer clopidogrel 75 mg orally once daily. 2. For patients with acute coronary syndrome (unstable angina or non-Q-wave myocardial infarction), start on the first day of treatment with a loading dose of 300 mg of this drug once daily, followed by a maintenance dose of 75 mg orally once daily. Aspirin 75 ~ 325 mg should be coadministered with this drug once daily. 3. For patients with atrial fibrillation, administer 75 mg of this drug orally once daily. Aspirin 75 ~ 100 mg should be coadministered with this drug once daily. ○ Patients with renal impairment : Treatment experience in patients with renal impairment is limited. ○ Patients with hepatic impairment : Treatment experience in patients with moderate hepatic disease and bleeding diathesis is limited. This drug may be administered with or without food.

Precautions

This medication helps prevent the aggregation of platelets in the blood, facilitating proper blood flow. It must be converted to its active form in the liver to be effective, and individuals with genetically reduced function of the liver enzyme CYP2C19 may experience reduced efficacy. In such cases, the risk of recurrence of heart or cerebrovascular diseases may increase, so it is advisable to consult a doctor about considering alternative treatment methods. Additionally, taking this medication with drugs that activate the CYP2C19 enzyme may increase the blood concentration of this medication, raising the risk of bleeding, so it is advisable not to take them together. Patients with a bleeding risk, those with bleeding tendencies, severe liver impairment, nursing mothers, individuals with lactose intolerance, and those with allergies to soybean oil, beans, or peanuts should not take this medication. Patients with bleeding lesions or abnormal blood coagulation, and those scheduled for upcoming surgery should use this medication cautiously. Before surgery, it may be necessary to discontinue the medication for several days. When taken with other antiplatelet agents, anticoagulants, non-steroidal anti-inflammatory drugs (NSAIDs), selective serotonin reuptake inhibitors (SSRIs), etc., the risk of bleeding may increase, hence caution is required. If symptoms of bleeding or adverse reactions occur during treatment with this medication, inform your doctor immediately and undergo necessary tests, including blood tests. Although the risks to the fetus during pregnancy have not been confirmed, there is a risk of bleeding at the time of delivery, so it is recommended to stop taking the medication before childbirth. In nursing, since this medication may be secreted into breast milk and could affect the baby, consult the doctor about whether to discontinue breastfeeding. The safety and efficacy in children have not been confirmed, and caution is needed in the elderly as they may experience side effects such as bleeding due to decreased bodily functions. Overdose may increase the risk of bleeding, and since there is no specific antidote, treatment such as platelet transfusion may be necessary in case of bleeding. This medication should be kept out of the reach of children and should not be transferred to another container.

Side effects

Hemorrhage, gastrointestinal bleeding, bleeding requiring hospitalization, purpura, contusion, hematoma, epistaxis, hematoma, hematuria, intraocular hemorrhage, intracranial hemorrhage, major hemorrhage, life-threatening hemorrhage, fatal hemorrhage, hemorrhagic stroke, blood transfusion required, skin and skin appendage adverse reactions, neutropenia, agranulocytosis, aplastic anemia, thrombocytopenia, abdominal pain, dyspepsia, diarrhea, rash, pruritus, chest pain, accidental injury, influenza-like illness, pain, fatigue, edema, hypertension, headache, dizziness, nausea, depression, upper respiratory tract infection, dyspnea, rhinitis, bronchitis, cough, urinary tract infection, decreased motor function, tremor, voice disorder, abnormal gait, hyperkinesia, ataxia, sensory disturbance, constipation, ulcer, loss of appetite, vomiting, hiccup, polydipsia, dysphagia, tongue disorders, insomnia, depression, forgetfulness, anxiety, somnolence, abnormal behavior, rigidity, facial edema, syncope, purpura, hematochezia, thrombocytopenia, anemia, hemothorax, pneumonia, sinusitis, eczema, skin ulcer, cystitis, cataract, conjunctivitis, gynecomastia, elevated prostate-specific antigen, allergic symptoms, ischemic necrosis, hemorrhagic arthropathy, hematuria, hemoptysis, retroperitoneal hemorrhage, surgical wound bleeding, pulmonary hemorrhage, vasculitis, hypotension, bronchospasm, interstitial pneumonia, eosinophilic pneumonia, colitis, pancreatitis, gastritis, stomatitis, hepatitis, acute liver failure, herpes zoster, erythema multiforme, maculopapular rash, urticaria, renal dysfunction, acute renal failure, cholecystitis, hematemesis, spinal hematoma, thrombotic thrombocytopenic purpura, confusion, hallucination, taste disturbance, taste loss, angioedema, vesicular dermatitis, drug-induced hypersensitivity syndrome, eosinophilia, drug rash, lichen planus, arthralgia, arthritis, myalgia, glomerulopathy, fever

Not everyone experiences these, and they can vary from person to person.

Storage

Store this medication in a tightly sealed container to protect it from air and moisture. It is important to maintain a storage temperature between 1 to 30 degrees Celsius to preserve its efficacy and safety for an extended period.

Appearance and packaging

Appearance

Pink round film-coated tablet

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.